| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0013125> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0021499> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0035363> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0085556> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0919747> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C0948245> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C1609165> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C2740854> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C2830231> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C2985546> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C3272237> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C5226663> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C5227770> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C5227771> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C5227772> <https://research.tib.eu/covid-19/entity/33002613_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Division of Infectious Diseases, USA.\', \'Department of Pharmacy Services, Kings County Hospital, Brooklyn, NY, USA.\', \'Division of Infectious Diseases, USA. Electronic address: marie.abdallah@nychhc.org.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Abdallah_Marie> <https://research.tib.eu/covid-19/entity/Balabayova_Khayala> <https://research.tib.eu/covid-19/entity/Gupta_Aanchal> <https://research.tib.eu/covid-19/entity/Kaminski_Monica_A> <https://research.tib.eu/covid-19/entity/Kaur_Avneet> <https://research.tib.eu/covid-19/entity/Quale_John> <https://research.tib.eu/covid-19/entity/Sunny_Subin>
?:doi	S1201-9712(20)32164-010.1016/j.ijid.2020.09.1447
?:doi	<https://research.tib.eu/covid-19/entity/S1201-9712%2820%2932164-010.1016/j.ijid.2020.09.1447>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Comparative_Study> <https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33002613>
?:pmid	<https://research.tib.eu/covid-19/entity/33002613>
?:pmid	33002613
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C1609165_ADMINISTERED_TO_C0030705>
?:title	Tocilizumab therapy for COVID-19: A comparison of subcutaneous and intravenous therapies.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33002613>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33002613>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all